| Preview | Issue Date | Title | Author(s) |
| 2012 | A novel retinoblastoma therapy from genomic and epigenetic analyses | Zhang, J.; Benavente, C.A.; McEvoy, J.; Flores-Otero, J.; Ding, L.; Chen, X.; Ulyanov, A.; Wu, G.; Wilson, M.; Wang, J.; Brennan, R.; Rusch, M.; Manning, A.L.; Ma, J.; Easton, J.; Shurtleff, S.; Mullighan, C.; Pounds, S.; Mukatira, S.; Gupta, P.; et al. |
| 2010 | Apixaban for reduction in stroke and other ThromboemboLic events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale | Lopes, R.; Alexander, J.; Al-Khatib, S.; Ansell, J.; Diaz, R.; Easton, J.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Hylek, E.; McMurray, J.; Verheugt, F.; Wallentin, L. |
| 2011 | Apixaban versus Warfarin in patients with atrial fibrillation | Granger, C.; Alexander, J.; McMurray, J.; Lopes, R.; Hylek, E.; Hanna, M.; Al-Khalidi, H.; Ansell, J.; Avezum, A.; Atar, D.; Bahit, M.; Diaz, R.; Easton, J.; Ezekowitz, J.; Garcia, D.; Geraldes, M.; Gersh, B.; Golitsyn, S.; Goto, S.; Hermosillo, A.; et al. |
| 2015 | CONSERTING: integrating copy-number analysis with structural-variation detection | Chen, X.; Gupta, P.; Wang, J.; Nakitandwe, J.; Roberts, K.; Dalton, J.D.; Parker, M.; Patel, S.; Holmfeldt, L.; Payne, D.; Easton, J.; Ma, J.; Rusch, M.; Wu, G.; Patel, A.; Baker, S.J.; Dyer, M.A.; Shurtleff, S.; Espy, S.; Pounds, S.; et al. |
| 2012 | Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial | Lopes, R.; Al-Khatib, S.; Wallentin, L.; Yang, H.; Ansell, J.; Bahit, M.; De Caterina, R.; Dorian, P.; Easton, J.; Erol, C.; Ezekowitz, J.; Gersh, B.; Granger, C.; Hohnloser, S.; Horowitz, J.; Hylek, E.; McMurray, J.; Mohan, P.; Vinereanu, D.; Alexander, J. |
| 2013 | Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia | Jaffe, J.D.; Wang, Y.; Chan, H.M.; Zhang, J.; Huether, R.; Kryukov, G.V.; Bhang, H.E.C.; Taylor, J.E.; Hu, M.; Englund, N.P.; Yan, F.; Wang, Z.; Mcdonald, E.R.; Wei, L.; Ma, J.; Easton, J.; Yu, Z.; Debeaumount, R.; Gibaja, V.; Venkatesan, K.; et al. |
| 2014 | Outcomes of children with BCR-ABL1-like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease | Roberts, K.; Pei, D.; Campana, D.; Payne-Turner, D.; Li, Y.; Cheng, C.; Sandlund, J.; Jeha, S.; Easton, J.; Becksfort, J.; Zhang, J.; Coustan-Smith, E.; Raimondi, S.; Leung, W.; Relling, M.; Evans, W.; Downing, J.; Mullighan, C.; Pui, C. |
| 2015 | Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia | Ma, X.; Edmonson, M.; Yergeau, D.; Muzny, D.; Hampton, O.; Rusch, M.; Song, G.; Easton, J.; Harvey, R.; Wheeler, D.; Ma, J.; Doddapaneni, H.; Vadodaria, B.; Wu, G.; Nagahawatte, P.; Carroll, W.; Chen, I.-M.; Gastier-Foster, J.; Relling, M.; Smith, M.; et al. |
| 2014 | Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia | Roberts, K.; Li, Y.; Payne-Turner, D.; Harvey, R.; Yang, Y.; Pei, D.; McCastlain, K.; Ding, L.; Lu, C.; Song, G.; Ma, J.; Becksfort, J.; Rusch, M.; Chen, S.; Easton, J.; Cheng, J.; Boggs, K.; Santiago-Morales, N.; Iacobucci, I.; Fulton, R.; et al. |
| 2012 | The genetic basis of early T-cell precursor acute lymphoblastic leukaemia | Zhang, J.; Ding, L.; Holmfeldt, L.; Wu, G.; Heatley, S.; Payne-Turner, D.; Easton, J.; Chen, X.; Wang, J.; Rusch, M.; Lu, C.; Chen, S.-C.; Wei, L.; Collins-Underwood, J.; Ma, J.; Roberts, K.; Pounds, S.; Ulyanov, A.; Becksfort, J.; Gupta, P.; et al. |
